Scleromyxedema with dermato-neuro syndrome

Journal of the American Academy of Dermatology

Volumn 42, Issue 5 II, 2000, Pages 927-928

  Gonzalez, Joselyn ^a   Palangio, Mark ^a   Schwartz, Joseph ^a   Klainer, Albert S ^a   Bisaccia, Emil ^a,b  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC ACTIVITY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; HUMAN; MALE; NEUROLOGIC DISEASE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY;

EID: 0034064869     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(00)90274-3     Document Type: Article

References (7)

1. Godby A, Bergstresser PR, Chaker B, Pandya AG. Fatal scleromyxedema: report of a case and review of literature. J Am Acad Dermatol 1998;38:289-94.
2. Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995;33:37-43.
3. Berkson M, Lazarus GS, Uberti-Benz M, Rook AH. Extracorporal photochemotherapy: a potentially useful treatment for scleromyxedema. J Amer Acad Dermatol 1991;25:724.
4. Krasagakis K, Zouboulis ChC, Owsianowski M, Ramaker J, Trautmann C, Tebbe B, et al. Remission of scleromyxedema following treatment with extracorporeal photopheresis. Br J Dermatol 1996;135:463-6.
5. Webster GF, Matsuoka LY, Burchmore D. The association of potentially lethal neurological syndromes with scleromyxedema (papular mucinosis). J Am Acad Dermatol 1993;28:105-8.
6. River Y, Levy I, Gilead L, Orbach H, Almong Y. Fever, convulsions and coma in scleromyxedema: a "dermato-neuro syndrome." Neurology 1996;46:1778-9.
7. Yu RK, Ariga T. The role of glycosphingolipids in neurological disorders: mechanisms of immune action. Ann N Y Acad Sci 1998;845:285-306.